相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The calcium signaling enzyme CD38-a paradigm for membrane topology defining distinct protein functions
Hon Cheung Lee et al.
CELL CALCIUM (2022)
Molecular dynamics of targeting CD38 in multiple myeloma
Fabio Malavasi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Evolving concepts in NAD+ metabolism
Claudia C. S. Chini et al.
CELL METABOLISM (2021)
Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment
Ryan M. Young et al.
IMMUNOLOGICAL REVIEWS (2019)
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab
Thomas G. Martin et al.
CELLS (2019)
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells
Xiaocui He et al.
EMBO JOURNAL (2018)
The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia
Alba Matas-Cespedes et al.
CLINICAL CANCER RESEARCH (2017)
The nanoscale spatial organization of B-cell receptors on immunoglobulin M- and G-expressing human B-cells
Jinmin Lee et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
Larysa Sanchez et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Martyn Plummer et al.
LANCET GLOBAL HEALTH (2016)
The nanoscale organization of the B lymphocyte membrane
Palash Chandra Maity et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Wiskott-Aldrich Syndrome Interacting Protein Deficiency Uncovers the Role of the Co-receptor CD19 as a Generic Hub for PI3 Kinase Signaling in B Cells
Selina Jessica Keppler et al.
IMMUNITY (2015)
Daratumumab granted breakthrough drug status
Jacob P. Laubach et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk
Kathrin Klaesener et al.
ELIFE (2014)
The Actin and Tetraspanin Networks Organize Receptor Nanoclusters to Regulate B Cell Receptor-Mediated Signaling
Pieta K. Mattila et al.
IMMUNITY (2013)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
Michel de Weers et al.
JOURNAL OF IMMUNOLOGY (2011)
Immunophenotyping in multiple myeloma and related plasma cell disorders
Shaji Kumar et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
The Membrane Skeleton Controls Diffusion Dynamics and Signaling through the B Cell Receptor
Bebhinn Treanor et al.
IMMUNITY (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Fabio Malavasi et al.
PHYSIOLOGICAL REVIEWS (2008)
CD38/CD19: a lipid raft-dependent signaling complex in human B cells
Silvia Deaglio et al.
BLOOD (2007)
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway
T Portis et al.
ONCOGENE (2004)
The RAF proteins take centre stage
C Wellbrock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells
S Deaglio et al.
BLOOD (2003)